ScholarIQanswers from OpenAlex

Chemotherapy and Survival Benefit in Elderly Patients With Advanced Non–Small-Cell Lung Cancer

PaperCitations, authors & open-access status

Chemotherapy and Survival Benefit in Elderly Patients With Advanced Non–Small-Cell Lung Cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Chemotherapy and Survival Benefit in Elderly Patients With Advanced Non–Small-Cell Lung Cancer have?

ScholarIQcitation count

Chemotherapy and Survival Benefit in Elderly Patients With Advanced Non–Small-Cell Lung Cancer has 292 citations in the OpenAlex counts ScholarIQ stores.

When was Chemotherapy and Survival Benefit in Elderly Patients With Advanced Non–Small-Cell Lung Cancer published?

ScholarIQyear

Chemotherapy and Survival Benefit in Elderly Patients With Advanced Non–Small-Cell Lung Cancer has 2010 year in the ScholarIQ index.

What is the open-access status of Chemotherapy and Survival Benefit in Elderly Patients With Advanced Non–Small-Cell Lung Cancer?

ScholarIQoa status

Chemotherapy and Survival Benefit in Elderly Patients With Advanced Non–Small-Cell Lung Cancer has bronze oa status in the ScholarIQ index.

What is the DOI of Chemotherapy and Survival Benefit in Elderly Patients With Advanced Non–Small-Cell Lung Cancer?

ScholarIQdoi

The DOI for Chemotherapy and Survival Benefit in Elderly Patients With Advanced Non–Small-Cell Lung Cancer is on the source record.

What is the PMID of Chemotherapy and Survival Benefit in Elderly Patients With Advanced Non–Small-Cell Lung Cancer?

ScholarIQpmid

The PMID for Chemotherapy and Survival Benefit in Elderly Patients With Advanced Non–Small-Cell Lung Cancer is on the source record.

What is the OpenAlex record for Chemotherapy and Survival Benefit in Elderly Patients With Advanced Non–Small-Cell Lung Cancer?

ScholarIQopenalex

The OpenAlex for Chemotherapy and Survival Benefit in Elderly Patients With Advanced Non–Small-Cell Lung Cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial